This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Sexually Transmitted Diseases Diagnostics Market

Market Insights on Sexually Transmitted Diseases Diagnostics covering sales outlook, demand forecast & up-to-date key trends

Sexually Transmitted Diseases Diagnostics Market by Types of Diseases, Diagnostic Test & Region - Forecast 2022 - 2032

Sexually Transmitted Diseases Diagnostics Market Outlook (2022-2032)

[300 Pages Report] The sexually transmitted diseases diagnostics market is anticipated to record a CAGR of 7.9% during the forecast period (2022 - 2032).

The sexually transmitted diseases diagnostics market is expected to be valued at US$ 3.8 Billion in 2022 and is likely to reach US$ 6.4 Billion by 2032.

"The rise in government bodies initiatives is a key factor that is driving the sexually transmitted diseases diagnostics market growth."

In the last decade, the prevalence and incidence of STDs have increased dramatically. With the rise in frequency, countries around the world are focused on implementing nationwide screening programmes to boost the adoption of sexually transmitted diseases diagnostics coverage. Furthermore, reimbursement policies for sexually transmitted diseases diagnostics services have been beneficial.

These reasons are contributing considerably to the worldwide sexually transmitted diseases diagnostics market's expansion.

The advancement of technologies, awareness regarding the infection, availability of better treatment, and many other factors are growing the demand for sexually transmitted diseases diagnostics.

Attributes

Details

Sexually transmitted diseases diagnostics Market CAGR

7.9%

Estimated Size 2022

US$ 3.8 Billion

Market Estimated Size 2032

US$ 6.4 Billion

Customize this Report

Let us know your requirement to get
100% FREE customization

What Changes has COVID-19 Brought About in the Sexually Transmitted Diseases Diagnostics Market?

The COVID-19 crisis has had a negative impact on the sexually transmitted diseases diagnostics market share. The sales of sexually transmitted diseases diagnostics kit are likely to decline due to disruptions to healthcare services and other STD test services.

As per the sexually transmitted diseases diagnostics market analysis, the demand for sexually transmitted diseases diagnostics testing is likely to reduce in the aftermath of the pandemic by 40%. During the lockdown, the number of testing devices available in the market has reduced significantly, thus changing the Sexually transmitted diseases diagnostics market outlook.

Demand for sexually transmitted diseases diagnostics has decreased due to the lack of awareness about the check-ups in the people who suffer from these infections and others who unwittingly spread the infection without any testing, especially in the developing and underdeveloped countries.

The lack of resources and critical care services in the sexually transmitted diseases diagnostics market segments has collapsed the sales of sexually transmitted diseases diagnostics kit.

In countries such as the US, the sexually transmitted diseases diagnostics market share is rising owing to the prevalence of STD in teenagers despite the influence of the pandemic.

What are the Key Sexually Transmitted Diseases Diagnostics Market Dynamics?

Demand for sexually transmitted disease diagnostics is likely to rise as the awareness regarding STD diseases rises among people towards the infection, boosting the Sexually transmitted diseases diagnostics market share during the forecast period.

The sexually transmitted diseases diagnostics market share is being driven by a significant rise in patient check-ups, campaigns, government initiatives, and growing awareness related to the infection and others.

Over the last decade, the sexually transmitted diseases diagnostics market share has been rising all around the globe. The advancements in Sexually transmitted diseases diagnostics devices are performing a key role in changing the market outlook.

Other important reasons driving the growth of the sexually transmitted diseases diagnostics market are increased public awareness and patient education. Furthermore, the demand for sexually transmitted diseases diagnostics is expected to develop due to an increase in the global prevalence of STDs, increased patient awareness through education programmes, and an increase in government initiatives.

The sexually transmitted diseases diagnostics market share is expected to grow high in the coming forecast period 2022-2032. The advanced level of diagnostic devices and betterment in the treatment plans are expected to lead to a growth in the demand for Sexually transmitted diseases diagnostics products.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Comparative View of Adjacent Sexually Transmitted Diseases Diagnostics Market

Sexually transmitted diseases diagnostics Market:

Attributes

Sexually transmitted diseases diagnostics Market

CAGR

(2022-2032)

7.9%

Market Value

(2026)

US$ 6.4 Billion

Growth Factor

Increased public awareness and patient education to drive the STD market growth.

Opportunity

Countries around the world are focused on implementing nationwide screening tests to boost the adoption of STD diagnostics.

Key Trends

The change from conventional methods to molecular diagnostics for the detection of STDs is driving the STD diagnostics market share.

HIV Diagnostics Market:

Attributes

HIV Diagnostics Market

CAGR

(2022-2032)

7.9%

Market Value

(2026)

US$ 4.07 Bn

Growth Factor

Rising global prevalence of HIV/AIDS, as well as the rising number of blood transfusions and blood donations.

Opportunity

Due to multiple advantages, the demand for technologically advanced PoC kits and instruments is on the rise

Key Trends

Key players' substantial investment in R&D efforts for the development of improved quality HIV testing kits for home use.

Point of Care Testing Market:

Attributes

Point of Care Testing Market

CAGR

(2022-2032)

7.4%

Market Value

(2026)

US$ 44.51 Bn

Growth Factor

POCT services have grown in popularity as the prevalence of chronic diseases and acute infections has increased around the world.

Opportunity

The demand for point of care tests for rapid diagnosis is growing due to their convenience of use, cost-effectiveness, and small product size.

Key Trends

POCT compliance, safety, and usability have become increasingly important as the scope of use and penetration in developing economies has grown.

STD diagnostics market growth is expected to be driven by an increase in patient awareness, such as education programmes and expanding government efforts. Furthermore, the growing number of people who have several casual sex partners is supporting the rise in demand for sexually transmitted diseases diagnostics.

The sexually transmitted diseases diagnostics market is expected to rise significantly over the projected period, owing to an increase in the number of technologically improved diagnostics tools that provide more precise testing findings.

Furthermore, a major transition from traditional laboratory testing to rapid point-of-care testing has been noted, which is fueling the sales of sexually transmitted diseases diagnostics with a technologically sophisticated product range that includes diagnostic kits, tools, and reagents.

What is the Segment Outlook for the Sexually Transmitted Diseases Diagnostics Market?

The STD diagnostics market is segmented on the basis of diseases type, location of testing, and region.

By disease type, the market is categorized into chlamydia, gonorrhoea, herpes simplex virus, syphilis, human papillomavirus (HPV), and other diseases (human immunodeficiency virus (HIV), chancroid, trichomoniasis, and hepatitis B). By location of testing, the STD diagnostics market is bifurcated into laboratory testing and point of care (POC) testing.

The laboratory testing segment of the STD diagnostics market accounted for the bulk of market share in the global sexually transmitted diseases diagnostics market in 2020 and is likely to remain dominant during the forecast period. Additionally, most of the diagnostic testing cases are performed in labs, which is expected to fuel the demand for STD diagnostics even more.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Which Segment is Anticipated to Dominate the Sexually Transmitted Diseases Diagnostics Market by Product?

Diagnostic laboratories are expected to dominate the Sexually transmitted diseases diagnostics market share with a CAGR of 7.2% in the forecast period 2022-2032. Due to continuous increases in technology and an increase in the number of tests in the laboratory, the demand for STD diagnostics is likely to expand in this segment.

The diagnostics laboratories are anticipated to rise in the Sexually transmitted diseases diagnostics market share in the forecast period 2022-2032.

Another segment which is experiencing a high rise in adoption is the point of care which is further expected to boost the demand for sexually transmitted diseases diagnostics testing. The changing market outlook and Sexually transmitted diseases diagnostics market trends are likely to positively impact the Sexually transmitted diseases diagnostics market share in the forthcoming years.

What is the Regional Analysis for the Sexually Transmitted Diseases Diagnostics Market?

Regions

CAGR

US Market

7.7%

UK Market

6.7%

China Market

7.2%

Japan Market

6.3%

South Korea Market

5.7%

The North American region is anticipated to dominate in the sexually transmitted diseases diagnostics market share due to the increase in demand for sexually transmitted diseases diagnostics tests. In the region, the U.S. is expected to boost the regional demand for Sexually transmitted diseases diagnostics. The U.S. captured a CAGR of 7.7% in the Sexually transmitted diseases diagnostics market share in the forecast period 2022-2032.

In the US, chlamydia type of STD infection is likely to rise as it is the most commonly found infection in the country. Teenage girls between 15-25-year-old young girls found infected by this disease lift the growth of sexually transmitted diseases diagnostics market share in the forecast period.

Around 1.8 million cases founded in the US in 2019, as per the report. The regional STD diagnostics market trends in the US are expected to drive the demand for STD diagnostics in the North American region.

Asia is expected as the second dominating region in the STD diagnostics market share. China has a vast number of STD diagnostics tests in the region which is expected to boost the demand in the region during the forecast period. A CAGR of 7.2% is likely to be captured in the STD diagnostics market by the China market during the forecast period 2022-2032.

Other regions such as the UK, Japan, and South Korea are expected to have a lower demand for STD diagnostics as compared to North America and the US market in the forecast period. The STD diagnostics market outlook in this region is mainly due to a lack of knowledge and delays in the test and treatment are leading to a fall in the STD diagnostics market share.

How Strong is the Competition in the Sexually Transmitted Diseases Diagnostics Market?

Key manufacturing companies are anticipated to boost the Sexually transmitted diseases diagnostics market share in the coming forecast period 2022-2032.

These companies are collaborating and entering into partnerships and joint ventures with the other industries to increase the growth of the sexually transmitted diseases diagnostics market share. The Food and Drug Administration of the US has cleared the CT/NG test to detect the infection, which is further boosting the Sexually transmitted diseases diagnostics market.

The sales of sexually transmitted diseases diagnostics testing products are likely to increase as demand is rising all around the globe.

Some recent developments in the sexually transmitted diseases diagnostics market include:

NASTAD (National Alliance of State and Territorial AIDS Directors) teamed with Building Healthy Online Communities in March 2021 to launch TakeMeHome, a free HIV and STD test kit home delivery initiative.

Ash, a sexual health firm, debuted STI at-home testing kits in September 2020. The exam consists of an online questionnaire that the respondent must complete before receiving personalised diagnostics.

Key Players

  • Abbott Laboratories
  • Bio-Rad laboratories
  • Qaigen Inc.
  • Diasorin SPA
  • MedMira Inc.
  • F.Hoffman
  • Hologic
  • Cepheid
  • BioMeriuex

Segments

By Types of Diseases:

  • Gonorrhea
  • Syphilis
  • Chlamydia
  • Herpes simple virus
  • Human papillomavirus
  • Others

By Diagnostic Test:

  • Cultural/Isolated of Organisms
  • Molecular Test
  • Immunology Assay
  • Other types of testing

By Device:

  • Laboratory Devices
    • Thermal Cyclers-PCR
    • Lteral Flow Readers Immunochromatographic Assay Flow Cytometers
    • Absorbance Microplate Readers Enzyme Linked Immunosorbent Assay
    • Others
  • Point of Sales
    • Phone Chips
    • Portable/Bench
    • Diagnostic Kits

By Location:

  • Laboratory
  • Point of Care

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Frequently Asked Questions

The sexually transmitted diseases diagnostics market is projected to register a CAGR of 7.9% during the forecast period (2022 - 2032).

During the forecast period, the US is expected to lead the sexually transmitted diseases diagnostics market with a CAGR of 7.7% through 2032.

Laboratories are expected to dominate the sexually transmitted diseases diagnostics market during the forecast period with a CAGR of 7.2% by the end of 2032.

The sexually transmitted diseases diagnostics market is poised to be worth US$ 6.4 Billion by 2032.

The sexually transmitted diseases diagnostics market size was valued at US$ 2.8 Billion in 2021.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook 

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage 

    2.2. Market Definition 

3. Market Risks and Trends Assessment 

    3.1. Risk Assessment 

        3.1.1. COVID-19 Crisis and Impact on Sexually Transmitted Diseases Diagnostics 

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis 

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background 

    4.1. Sexually Transmitted Diseases Diagnostics Market, by Key Countries

    4.2. Sexually Transmitted Diseases Diagnostics Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast 

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario 

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Sexually Transmitted Diseases Diagnostics Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Sexually Transmitted Diseases Diagnostics Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors 

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking 

6. Global Sexually Transmitted Diseases Diagnostics Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Sexually Transmitted Diseases Diagnostics Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Sexually Transmitted Diseases Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Disease 

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Disease , 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease , 2022-2032

        8.3.1. Chlamydiya

        8.3.2. Gonorrhea

        8.3.3. Syphilis

        8.3.4. Genital Herpes

        8.3.5. Hepatities B

        8.3.6. HIV/AIDS

        8.3.7. Human Papillomavirus(HPV)

        8.3.8. Others

    8.4. Market Attractiveness Analysis By Disease 

9. Global Sexually Transmitted Diseases Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Diagnostic Test 

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Diagnostic Test , 2015-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Diagnostic Test , 2022-2032

        9.3.1. Culture/Isolation Of Organisms

        9.3.2. Molecular Test

        9.3.3. Immunology Assay 

        9.3.4. Other Type of Testing

    9.4. Market Attractiveness Analysis By Diagnostic Test 

10. Global Sexually Transmitted Diseases Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Location Of Diagnostic Test 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Location Of Diagnostic Test , 2015-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Location Of Diagnostic Test , 2022-2032

        10.3.1. Laboratory Testing

        10.3.2. Point Of Care (PoC) Testing

    10.4. Market Attractiveness Analysis By Location Of Diagnostic Test 

11. Global Sexually Transmitted Diseases Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Devices 

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Devices , 2015-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Devices , 2022-2032

        11.3.1. Laboratory Devices

            11.3.1.1. Thermal Cyclers-PCR

            11.3.1.2. Lateral Flow Readers Immunochromatographic Assays Flow Cytometers

            11.3.1.3. Absorbance Microplate Reader Enzyme Linked Immunosorbent Assay (ELISA)

            11.3.1.4. Others

        11.3.2. Pont Of Care (PoC) Devices

            11.3.2.1. Phone Chips (Microfluidics + ICT)

            11.3.2.2. Portable/Bench

            11.3.2.3. Diagnostics Kits

    11.4. Market Attractiveness Analysis By Devices 

12. Global Sexually Transmitted Diseases Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    12.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. Asia Pacific 

        12.3.5. Middle East and Africa (MEA)

    12.4. Market Attractiveness Analysis By Region

13. North America Sexually Transmitted Diseases Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. U.S.

            13.4.1.2. Canada

            13.4.1.3. Rest of North America

        13.4.2. By Disease 

        13.4.3. By Diagnostic Test 

        13.4.4. By Devices 

        13.4.5. By Location Of Diagnostic Test 

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Disease 

        13.5.3. By Diagnostic Test 

        13.5.4. By Devices 

        13.5.5. By Location Of Diagnostic Test 

14. Latin America Sexually Transmitted Diseases Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. Brazil

            14.4.1.2. Mexico

            14.4.1.3. Rest of Latin America

        14.4.2. By Disease 

        14.4.3. By Diagnostic Test 

        14.4.4. By Devices 

        14.4.5. By Location Of Diagnostic Test 

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Disease 

        14.5.3. By Diagnostic Test 

        14.5.4. By Devices 

        14.5.5. By Location Of Diagnostic Test 

15. Europe Sexually Transmitted Diseases Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. Germany

            15.4.1.2. France

            15.4.1.3. U.K.

            15.4.1.4. Italy

            15.4.1.5. Benelux

            15.4.1.6. Nordic Countries

            15.4.1.7. Rest of Europe

        15.4.2. By Disease 

        15.4.3. By Diagnostic Test 

        15.4.4. By Devices 

        15.4.5. By Location Of Diagnostic Test 

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Disease 

        15.5.3. By Diagnostic Test 

        15.5.4. By Devices 

        15.5.5. By Location Of Diagnostic Test 

16. Asia Pacific Sexually Transmitted Diseases Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. China

            16.4.1.2. Japan

            16.4.1.3. South Korea

            16.4.1.4. Rest of Asia Pacific

        16.4.2. By Disease 

        16.4.3. By Diagnostic Test 

        16.4.4. By Devices 

        16.4.5. By Location Of Diagnostic Test 

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Disease 

        16.5.3. By Diagnostic Test 

        16.5.4. By Devices 

        16.5.5. By Location Of Diagnostic Test 

17. Middle East and Africa Sexually Transmitted Diseases Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        17.4.1. By Country

            17.4.1.1. GCC Countries

            17.4.1.2. South Africa

            17.4.1.3. Turkey

            17.4.1.4. Rest of Middle East and Africa

        17.4.2. By Disease 

        17.4.3. By Diagnostic Test 

        17.4.4. By Devices 

        17.4.5. By Location Of Diagnostic Test 

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Disease 

        17.5.3. By Diagnostic Test 

        17.5.4. By Devices 

        17.5.5. By Location Of Diagnostic Test 

18. Key Countries Sexually Transmitted Diseases Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    18.1. Introduction

        18.1.1. Market Value Proportion Analysis, By Key Countries

        18.1.2. Global Vs. Country Growth Comparison

    18.2. US Sexually Transmitted Diseases Diagnostics Market Analysis

        18.2.1. Value Proportion Analysis by Market Taxonomy

        18.2.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.2.2.1. By Disease 

            18.2.2.2. By Diagnostic Test 

            18.2.2.3. By Devices 

            18.2.2.4. By Location Of Diagnostic Test 

    18.3. Canada Sexually Transmitted Diseases Diagnostics Market Analysis

        18.3.1. Value Proportion Analysis by Market Taxonomy

        18.3.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.3.2.1. By Disease 

            18.3.2.2. By Diagnostic Test 

            18.3.2.3. By Devices 

            18.3.2.4. By Location Of Diagnostic Test 

    18.4. Mexico Sexually Transmitted Diseases Diagnostics Market Analysis

        18.4.1. Value Proportion Analysis by Market Taxonomy

        18.4.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.4.2.1. By Disease 

            18.4.2.2. By Diagnostic Test 

            18.4.2.3. By Devices 

            18.4.2.4. By Location Of Diagnostic Test 

    18.5. Brazil Sexually Transmitted Diseases Diagnostics Market Analysis

        18.5.1. Value Proportion Analysis by Market Taxonomy

        18.5.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.5.2.1. By Disease 

            18.5.2.2. By Diagnostic Test 

            18.5.2.3. By Devices 

            18.5.2.4. By Location Of Diagnostic Test 

    18.6. Germany Sexually Transmitted Diseases Diagnostics Market Analysis

        18.6.1. Value Proportion Analysis by Market Taxonomy

        18.6.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.6.2.1. By Disease 

            18.6.2.2. By Diagnostic Test 

            18.6.2.3. By Devices 

            18.6.2.4. By Location Of Diagnostic Test 

    18.7. France Sexually Transmitted Diseases Diagnostics Market Analysis

        18.7.1. Value Proportion Analysis by Market Taxonomy

        18.7.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.7.2.1. By Disease 

            18.7.2.2. By Diagnostic Test 

            18.7.2.3. By Devices 

            18.7.2.4. By Location Of Diagnostic Test 

    18.8. Italy Sexually Transmitted Diseases Diagnostics Market Analysis

        18.8.1. Value Proportion Analysis by Market Taxonomy

        18.8.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.8.2.1. By Disease 

            18.8.2.2. By Diagnostic Test 

            18.8.2.3. By Devices 

            18.8.2.4. By Location Of Diagnostic Test 

    18.9. BENELUX Sexually Transmitted Diseases Diagnostics Market Analysis

        18.9.1. Value Proportion Analysis by Market Taxonomy

        18.9.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.9.2.1. By Disease 

            18.9.2.2. By Diagnostic Test 

            18.9.2.3. By Devices 

            18.9.2.4. By Location Of Diagnostic Test 

    18.10. UK Sexually Transmitted Diseases Diagnostics Market Analysis

        18.10.1. Value Proportion Analysis by Market Taxonomy

        18.10.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.10.2.1. By Disease 

            18.10.2.2. By Diagnostic Test 

            18.10.2.3. By Devices 

            18.10.2.4. By Location Of Diagnostic Test 

    18.11. Nordic Countries Sexually Transmitted Diseases Diagnostics Market Analysis

        18.11.1. Value Proportion Analysis by Market Taxonomy

        18.11.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.11.2.1. By Disease 

            18.11.2.2. By Diagnostic Test 

            18.11.2.3. By Devices 

            18.11.2.4. By Location Of Diagnostic Test 

    18.12. China Sexually Transmitted Diseases Diagnostics Market Analysis

        18.12.1. Value Proportion Analysis by Market Taxonomy

        18.12.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.12.2.1. By Disease 

            18.12.2.2. By Diagnostic Test 

            18.12.2.3. By Devices 

            18.12.2.4. By Location Of Diagnostic Test 

    18.13. Japan Sexually Transmitted Diseases Diagnostics Market Analysis

        18.13.1. Value Proportion Analysis by Market Taxonomy

        18.13.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.13.2.1. By Disease 

            18.13.2.2. By Diagnostic Test 

            18.13.2.3. By Devices 

            18.13.2.4. By Location Of Diagnostic Test 

    18.14. South Korea Sexually Transmitted Diseases Diagnostics Market Analysis

        18.14.1. Value Proportion Analysis by Market Taxonomy

        18.14.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.14.2.1. By Disease 

            18.14.2.2. By Diagnostic Test 

            18.14.2.3. By Devices 

            18.14.2.4. By Location Of Diagnostic Test 

    18.15. GCC Countries Sexually Transmitted Diseases Diagnostics Market Analysis

        18.15.1. Value Proportion Analysis by Market Taxonomy

        18.15.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.15.2.1. By Disease 

            18.15.2.2. By Diagnostic Test 

            18.15.2.3. By Devices 

            18.15.2.4. By Location Of Diagnostic Test 

    18.16. South Africa Sexually Transmitted Diseases Diagnostics Market Analysis

        18.16.1. Value Proportion Analysis by Market Taxonomy

        18.16.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.16.2.1. By Disease 

            18.16.2.2. By Diagnostic Test 

            18.16.2.3. By Devices 

            18.16.2.4. By Location Of Diagnostic Test 

    18.17. Turkey Sexually Transmitted Diseases Diagnostics Market Analysis

        18.17.1. Value Proportion Analysis by Market Taxonomy

        18.17.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032

            18.17.2.1. By Disease 

            18.17.2.2. By Diagnostic Test 

            18.17.2.3. By Devices 

            18.17.2.4. By Location Of Diagnostic Test 

        18.17.3. Competition Landscape and Player Concentration in the Country

19. Market Structure Analysis

    19.1. Market Analysis by Tier of Companies 

    19.2. Market Concentration

    19.3. Market Share Analysis of Top Players

    19.4. Market Presence Analysis

        19.4.1. By Regional footprint of Players

        19.4.2. Product footprint by Players

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competition Deep Dive 

        20.3.1. Abbott Laboratories 

            20.3.1.1. Overview

            20.3.1.2. Product Portfolio

            20.3.1.3. Sales Footprint

            20.3.1.4. Strategy Overview

        20.3.2. Cephied (Danaher Corporation)

            20.3.2.1. Overview

            20.3.2.2. Product Portfolio

            20.3.2.3. Sales Footprint

            20.3.2.4. Strategy Overview

        20.3.3. Diasorin S.p.A

            20.3.3.1. Overview

            20.3.3.2. Product Portfolio

            20.3.3.3. Sales Footprint

            20.3.3.4. Strategy Overview

        20.3.4. Hologic Inc

            20.3.4.1. Overview

            20.3.4.2. Product Portfolio

            20.3.4.3. Sales Footprint

            20.3.4.4. Strategy Overview

        20.3.5. Siemens AG

            20.3.5.1. Overview

            20.3.5.2. Product Portfolio

            20.3.5.3. Sales Footprint

            20.3.5.4. Strategy Overview

        20.3.6. Medmira Inc

            20.3.6.1. Overview

            20.3.6.2. Product Portfolio

            20.3.6.3. Sales Footprint

            20.3.6.4. Strategy Overview

        20.3.7. Qiagen INC 

            20.3.7.1. Overview

            20.3.7.2. Product Portfolio

            20.3.7.3. Sales Footprint

            20.3.7.4. Strategy Overview

        20.3.8. BioMeriuex

            20.3.8.1. Overview

            20.3.8.2. Product Portfolio

            20.3.8.3. Sales Footprint

            20.3.8.4. Strategy Overview

        20.3.9. Bio-Rad Laboratories

            20.3.9.1. Overview

            20.3.9.2. Product Portfolio

            20.3.9.3. Sales Footprint

            20.3.9.4. Strategy Overview

        20.3.10. Thermo Fisher Corporation

            20.3.10.1. Overview

            20.3.10.2. Product Portfolio

            20.3.10.3. Sales Footprint

            20.3.10.4. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn),By Disease , 2015 – 2021

Table 2: Global Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn),By Disease , 2022 – 2032

Table 3: Global Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Diagnostic Test , 2015 – 2021

Table 4: Global Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Diagnostic Test , 2022 – 2032

Table 5: Global Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Location Of Diagnostic Test , 2015 – 2021

Table 6: Global Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Location Of Diagnostic Test , 2022 – 2032

Table 7: Global Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Devices , 2015 – 2021

Table 8: Global Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Devices , 2022 – 2032

Table 9: Global Sexually Transmitted Diseases Diagnostics Market, By Region, 2015 – 2021

Table 10: Global Sexually Transmitted Diseases Diagnostics Market, By Region, 2022 – 2032

Table 11: North America Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn),By Disease , 2015 – 2021

Table 12: North America Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn),By Disease , 2022 – 2032

Table 13: North America Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Diagnostic Test , 2015 – 2021

Table 14: North America Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Diagnostic Test , 2022 – 2032

Table 15: North America Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Location Of Diagnostic Test , 2015 – 2021

Table 16: North America Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Location Of Diagnostic Test , 2022 – 2032

Table 17: North America Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Devices , 2015 – 2021

Table 18: North America Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Devices , 2022 – 2032

Table 19: North America Sexually Transmitted Diseases Diagnostics Market, By Country, 2015 – 2021

Table 20: North America Sexually Transmitted Diseases Diagnostics Market, By Country, 2022 – 2032

Table 21: Latin America Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn),By Disease , 2015 – 2021

Table 22: Latin America Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn),By Disease , 2022 – 2032

Table 23: Latin America Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Diagnostic Test , 2015 – 2021

Table 24: Latin America Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Diagnostic Test , 2022 – 2032

Table 25: Latin America Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Location Of Diagnostic Test , 2015 – 2021

Table 26: Latin America Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Location Of Diagnostic Test , 2022 – 2032

Table 27: Latin America Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Devices , 2015 – 2021

Table 28: Latin America Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Devices , 2022 – 2032

Table 29: Latin America Sexually Transmitted Diseases Diagnostics Market, By Country, 2015 – 2021

Table 30: Latin America Sexually Transmitted Diseases Diagnostics Market, By Country, 2022 – 2032

Table 31: Europe Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn),By Disease , 2015 – 2021

Table 32: Europe Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn),By Disease , 2022 – 2032

Table 33: Europe Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Diagnostic Test , 2015 – 2021

Table 34: Europe Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Diagnostic Test , 2022 – 2032

Table 35: Europe Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Location Of Diagnostic Test , 2015 – 2021

Table 36: Europe Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Location Of Diagnostic Test , 2022 – 2032

Table 37: Europe Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Devices , 2015 – 2021

Table 38: Europe Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Devices , 2022 – 2032

Table 39: Europe Sexually Transmitted Diseases Diagnostics Market, By Country, 2015 – 2021

Table 40: Europe Sexually Transmitted Diseases Diagnostics Market, By Country, 2022 – 2032

Table 41: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn),By Disease , 2015 – 2021

Table 42: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn),By Disease , 2022 – 2032

Table 43: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Diagnostic Test , 2015 – 2021

Table 44: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Diagnostic Test , 2022 – 2032

Table 45: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Location Of Diagnostic Test , 2015 – 2021

Table 46: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Location Of Diagnostic Test , 2022 – 2032

Table 47: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Devices , 2015 – 2021

Table 48: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Devices , 2022 – 2032

Table 49: Asia Pacific Sexually Transmitted Diseases Diagnostics Market, By Country, 2015 – 2021

Table 50: Asia Pacific Sexually Transmitted Diseases Diagnostics Market, By Country, 2022 – 2032

Table 51: MEA Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn),By Disease , 2015 – 2021

Table 52: MEA Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn),By Disease , 2022 – 2032

Table 53: MEA Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Diagnostic Test , 2015 – 2021

Table 54: MEA Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Diagnostic Test , 2022 – 2032

Table 55: MEA Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Location Of Diagnostic Test , 2015 – 2021

Table 56: MEA Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Location Of Diagnostic Test , 2022 – 2032

Table 57: MEA Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Devices , 2015 – 2021

Table 58: MEA Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn), By Devices , 2022 – 2032

Table 59: MEA Sexually Transmitted Diseases Diagnostics Market, By Country, 2015 – 2021

Table 60: MEA Sexually Transmitted Diseases Diagnostics Market, By Country, 2022 – 2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Global Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 2: Global Sexually Transmitted Diseases Diagnostics Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global Sexually Transmitted Diseases Diagnostics Market Share, By Disease , 2022 & 2032

Figure 4: Global Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Disease – 2022-2032

Figure 5: Global Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Disease – 2022-2032

Figure 6: Global Sexually Transmitted Diseases Diagnostics Market Share, By Diagnostic Test , 2022 & 2032

Figure 7: Global Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Diagnostic Test – 2022-2032

Figure 8: Global Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Diagnostic Test – 2022-2032

Figure 9: Global Sexually Transmitted Diseases Diagnostics Market Share, By Devices , 2022 & 2032

Figure 10: Global Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Devices – 2022-2032

Figure 11: Global Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Devices – 2022-2032

Figure 12: Global Sexually Transmitted Diseases Diagnostics Market Share, By Location Of Diagnostic Test , 2022 & 2032

Figure 13: Global Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Location Of Diagnostic Test – 2022-2032

Figure 14: Global Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Location Of Diagnostic Test – 2022-2032

Figure 15: Global Sexually Transmitted Diseases Diagnostics Market Share, By Region, 2022 & 2032

Figure 16: Global Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 17: Global Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Region – 2022-2032

Figure 18: North America Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 19: North America Sexually Transmitted Diseases Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 20: North America Sexually Transmitted Diseases Diagnostics Market Share, By Disease , 2022 & 2032

Figure 21: North America Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Disease – 2022-2032

Figure 22: North America Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Disease – 2022-2032

Figure 23: North America Sexually Transmitted Diseases Diagnostics Market Share, By Diagnostic Test , 2022 & 2032

Figure 24: North America Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Diagnostic Test – 2022-2032

Figure 25: North America Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Diagnostic Test – 2022-2032

Figure 26: North America Sexually Transmitted Diseases Diagnostics Market Share, By Devices , 2022 & 2032

Figure 27: North America Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Devices – 2022-2032

Figure 28: North America Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Devices – 2022-2032

Figure 29: North America Sexually Transmitted Diseases Diagnostics Market Share, By Location Of Diagnostic Test , 2022 & 2032

Figure 30: North America Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Location Of Diagnostic Test – 2022-2032

Figure 31: North America Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Location Of Diagnostic Test – 2022-2032

Figure 32: North America Sexually Transmitted Diseases Diagnostics Market Share, By Country, 2022 & 2032

Figure 33: North America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 34: North America Market Attractiveness Index, By Country – 2022-2032

Figure 35: Latin America Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 36: Latin America Sexually Transmitted Diseases Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 37: Latin America Sexually Transmitted Diseases Diagnostics Market Share, By Disease , 2022 & 2032

Figure 38: Latin America Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Disease – 2022-2032

Figure 39: Latin America Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Disease – 2022-2032

Figure 40: Latin America Sexually Transmitted Diseases Diagnostics Market Share, By Diagnostic Test , 2022 & 2032

Figure 41: Latin America Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Diagnostic Test – 2022-2032

Figure 42: Latin America Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Diagnostic Test – 2022-2032

Figure 43: Latin America Sexually Transmitted Diseases Diagnostics Market Share, By Devices , 2022 & 2032

Figure 44: Latin America Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Devices – 2022-2032

Figure 45: Latin America Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Devices – 2022-2032

Figure 46: Latin America Sexually Transmitted Diseases Diagnostics Market Share, By Location Of Diagnostic Test , 2022 & 2032

Figure 47: Latin America Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Location Of Diagnostic Test – 2022-2032

Figure 48: Latin America Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Location Of Diagnostic Test – 2022-2032

Figure 49: Latin America Sexually Transmitted Diseases Diagnostics Market Share, By Country, 2022 & 2032

Figure 50: Latin America Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 51: Latin America Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Country – 2022-2032

Figure 52: Europe Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 53: Europe Sexually Transmitted Diseases Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 54: Europe Sexually Transmitted Diseases Diagnostics Market Share, By Disease , 2022 & 2032

Figure 55: Europe Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Disease – 2022-2032

Figure 56: Europe Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Disease – 2022-2032

Figure 57: Europe Sexually Transmitted Diseases Diagnostics Market Share, By Diagnostic Test , 2022 & 2032

Figure 58: Europe Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Diagnostic Test – 2022-2032

Figure 59: Europe Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Diagnostic Test – 2022-2032

Figure 60: Europe Sexually Transmitted Diseases Diagnostics Market Share, By Devices , 2022 & 2032

Figure 61: Europe Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Devices – 2022-2032

Figure 62: Europe Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Devices – 2022-2032

Figure 63: Europe Sexually Transmitted Diseases Diagnostics Market Share, By Location Of Diagnostic Test , 2022 & 2032

Figure 64: Europe Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Location Of Diagnostic Test – 2022-2032

Figure 65: Europe Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Location Of Diagnostic Test – 2022-2032

Figure 66: Europe Sexually Transmitted Diseases Diagnostics Market Share, By Country, 2022 & 2032

Figure 67: Europe Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 68: Europe Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Country – 2022-2032

Figure 69: MEA Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 70: MEA Sexually Transmitted Diseases Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 71: MEA Sexually Transmitted Diseases Diagnostics Market Share, By Disease , 2022 & 2032

Figure 72: MEA Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Disease – 2022-2032

Figure 73: MEA Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Disease – 2022-2032

Figure 74: MEA Sexually Transmitted Diseases Diagnostics Market Share, By Diagnostic Test , 2022 & 2032

Figure 75: MEA Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Diagnostic Test – 2022-2032

Figure 76: MEA Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Diagnostic Test – 2022-2032

Figure 77: MEA Sexually Transmitted Diseases Diagnostics Market Share, By Devices , 2022 & 2032

Figure 78: MEA Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Devices – 2022-2032

Figure 79: MEA Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Devices – 2022-2032

Figure 80: MEA Sexually Transmitted Diseases Diagnostics Market Share, By Location Of Diagnostic Test , 2022 & 2032

Figure 81: MEA Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Location Of Diagnostic Test – 2022-2032

Figure 82: MEA Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Location Of Diagnostic Test – 2022-2032

Figure 83: MEA Sexually Transmitted Diseases Diagnostics Market Share, By Country, 2022 & 2032

Figure 84: MEA Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 85: MEA Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Country – 2022-2032

Figure 86: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 87: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 88: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Share, By Disease , 2022 & 2032

Figure 89: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Disease – 2022-2032

Figure 90: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Disease – 2022-2032

Figure 91: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Share, By Diagnostic Test , 2022 & 2032

Figure 92: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Diagnostic Test – 2022-2032

Figure 93: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Diagnostic Test – 2022-2032

Figure 94: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Share, By Devices , 2022 & 2032

Figure 95: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Devices – 2022-2032

Figure 96: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Devices – 2022-2032

Figure 97: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Share, By Location Of Diagnostic Test , 2022 & 2032

Figure 98: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Location Of Diagnostic Test – 2022-2032

Figure 99: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Location Of Diagnostic Test – 2022-2032

Figure 100: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Share, By Country, 2022 & 2032

Figure 101: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 102: Asia Pacific Sexually Transmitted Diseases Diagnostics Market Attractiveness Index, By Country – 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Poultry Diagnostics Market

Published : November 2020

Healthcare

Infectious Disease Diagnostics Market

Published : January 2016

Healthcare

Cancer Diagnostics Market

Published : March 2021

Healthcare

Tissue Diagnostics Market

Published : July 2020

Google translate

Sexually Transmitted Diseases Diagnostics Market